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Abstract 
Aim: The aim of this study was to evaluate the genotoxic effect of docetaxel on the human adenocarcinoma MCF-7 cells 
to detect genetic variations and discover potential associations between the drug and the genotoxic damage of MCF-7 
cells. Materials and Methods: High resolution melt analysis (HRM) of genomic DNA isolated from MCF-7 cells was 
used. Two primers of MDR1 gene were selected: 5´-TGGGGCTTTTAGTGTTGGAC-3´,  
5´-TGTGGAGAGCTGGATAAAGTCA-3´. Results: The significant alterations in the melting temperature Tm of DNA 
treated with docetaxel in the concentrations of 1 μmol/l and 250 μmol/l were observed. Comparing G+C/A+T ratios 
the increase of the relative content of G, C was detected. Minor changes of the nucleotide content were observed when 
compared the sequences of DNA for the control and the docetaxel treated group.Conclusions: Using MDR1 primer 
pairs, our results confirmed that MCF-7 cells are susceptible to genomic DNA instability when exposed to docetaxel.  
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/ŶƐƚƌŽĚƵĐƚŝŽŶ  
 
Systematic chemotherapy and hormonal therapy is 
the most essential factor in reducing mortality in breast 
cancer patients. Among diverse chemotherapies, 
docetaxel provides both symptomatic and survival 
benefits in early breast cancer patients but did not 
improve survival in metastatic breast cancer trials [1]. 
The response rate to docetaxel is 40-60 % even in first-
line chemotherapy and it decreases to 20-30 % in the 
second-or third-line chemotherapy [2]. Docetaxel is a 
semi-synthetic, second-generation taxane derived from 
a compound found in the yew tree Taxus baccata [3]. 
Taxanes exHUW WKHLU HIIHFWV E\ ELQGLQJ WR ȕ-tubulin 
subunits of microtubules. By stabilizing microtubules, 
docetaxel prevents the dynamic polymerization/de-
polymerization processes essential during mitosis [4]. 
In this way, apoptosis is induced by blocking cell 
growth in the G2-M phase by disrupting normal mitotic 
spindle formation. Moreover, additional signal 
transduction pathways involved in apoptosis have also 
been suggested [5, 6]. Caspase-3 actively participates 
in apoptosis of various tumor cells [7] and activation of 
caspase-3-dependent pathway has been also regarded 
as the triggering event of apoptosis induced by taxanes. 
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In addition, it was shown that the treatment with 
docetaxel leads to DNA fragmentation [8, 9].  
Furthermore, mechanisms of sensitivity or resistance 
to anticancer chemotherapy still remains not fully 
understood. Numerous tumor drug resistance 
mechanisms have been demonstrated that attempt to 
explain mechanisms involved in the resistance to 
chemotherapeutic agents such as decreased drug 
transport inside the tumor cells or enhanced drug 
efflux, increased capability of cancer cells to stop 
cycling and increased tolerance to drug-induced 
damage to DNA [10, 11].  
Multidrug resistance, in which cancerous tissues 
exhibit decreased sensitivity to diverse drugs is by far 
the most studied form of anticancer drug resistance. 
Overexpression of P-glycoprotein (P-gp) – the product 
of the multidrug resistance 1 (MDR1/ABCB1) gene, in 
cancer cells resistant to a variety of anti-tumour 
alkaloids and antibiotics confirmed clinically is one of 
the best studied and characterized. However, P-gp itself 
may have a direct influence on the function of proteins 
involved in regulatory pathways, including apoptotic 
progression (such as p53, caspase-3 and pokemon) [12, 
13]. A growing number of preclinical and clinical 
studies have demonstrated that polymorphism of the 
MDR1 gene may be a factor in the overall outcome of 
pharmacotherapy for numerous diseases [7].  
High resolution melting (HRM) analysis is an 
attractive platform to cope with broad spectrum of 
human genetic mutations [14] and polymorphisms [15] 
as it is single step, closed tube, and cost-effective. 
HRM includes the precise monitoring of the variation 
in fluorescence initiated by the release of an 
intercalating DNA dye from a DNA duplex as it is 
denatured by increasing temperature. The accuracy of 
the melt curve is maximized by acquiring fluorescence 
data over as low temperature increments as 0.01°C.  
Considering the fact that the low chemotherapeutic 
efficiency in cancer patients is related with resistance 
of cytostatic agents and DNA belongs to the main 
targets of many conventional anticancer agents, the aim 
of our study was to evaluate the genotoxic effects of 
docetaxel to detect potential associations between the 
drug sensitivities and the genotoxic damage of MCF-7 
cell line compared with control untreated MCF-7 cells 
using HRM analysis. Likewise, real-time polymerase 
chain reaction analyses were selected to determine the 
genetic DNA expression levels of the MDR1 gene. 
 
DĂƚĞƌŝĂůƐĂŶĚDĞƚŽĚƐ  
Cell Growth Conditions and Cell Passaging 
The MCF-7 cell line was purchased from the 
American Type Culture Collection (ATCC, USA). 
Cells were grown according to the procedure of 
7UHEXĖRYi HW DO  >@ %ULHIO\ D PRQROD\HU RI
cells were cultured in 10% Dulbecco's Modified Eagle 
Medium (Invitrogen, USA) containing fetal bovine 
serum (FBS, Invitrogen), mixture of 5000 units of 
penicillin and 5000 μg of streptomycin/ml in 0.85 % 
saline (PenStrep) (Invitrogen, USA). Cells were kept in 
the Heracell 150i incubator (Thermo Scientific, USA) 
at 37 °C in 5 % CO2 and 95 % humidity. All solutions 
used were of the cell culture grade quality. The 
equipment employed was commercially pre-sterilized 
and disposable.  
 
Drugs 
Docetaxel were kindly provided by Dr. Andrašina 
(UPJS Kosice, Faculty of Medicine, Department of 
Oncology). Drug was stored at room temperature in 
polysorbate 80 as 40 mg/ml concentrate. The solutions 
of cytostatics were vigorously stirred before dilution in 
the filtered cell culture medium and stored at 20°C. 
Cytostatics were directly applied into the culture 
medium to obtain the final concentrations  
1 μmol/l, 3 μmol/l, 50 μmol/l, 100 μmol/l, and 250 
μmol/l. The cells were allowed to grow for 2.5 hours 
and were subsequently treated with fresh medium, after 
which point they were incubated for 60 hours at 37 °C. 
After 60 h of exposure, the cells were three times 
washed with phosphate buffer saline (PBS), pelleted 
and stored at -80 °C.  
 
DNA samples 
DNA samples were extracted from both non-affected 
and docetaxel-treated MCF-7 cells. Pellets were 
resuspended in lysis buffer and DNA was isolated 
according to the manufacturer´s protocol 
(SensiFASTTM SYBR, No-ROX Kit, Bioline, UK). 
The concentration of DNA was determined 
spectrophotometrycally with NanoPhotometerTM 
(Implen, Germany): MCF-7/c - 78 ng/Pl, MCF-7/1 - 63 
ng/Pl, MCF-7/250 - 62 ng/Pl. 
 
Melting analysis 
Two primers (Sigma, USA), where DNA fragment is 
between exon 14 and intron 14 of MDR1 gene, were 
selected [17]. As a forward primer and a backward 
primer were used respectively  
5´-TGGGGCTTTTAGTGTTGGAC-3´ and  
5´-TGTGGAGAGCTGGATAAAGTCA-3´.  
PCR amplification and melting analysis were 
performed on the Line Gene K (Bioer, China) using 
FastStart Universal SYBR Green Master (ROX) 
(Roche, Switzerland) as recommended by the 
manufacturer. The cycling protocol started with one 
cycle of 50 °C for 2 min followed by one cycle of 
95 °C for 10 min followed by 99 cycles of 95 °C for 15 
s (1 °C/cycle), a touch down of 95 °C to 61.2 °C for 1 
min. The melting analysis step started of 61.2 °C to 
target temperature of 95 °C for 15 s (0.5 °C/cycle). 
Fluorescence data were converted into melting peaks 
by the aid of fluorescence quantitative PCR detection 
software (Line-Gene K, Bioer, China) to determine 
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binding efficiency of DNA exposed to docetaxel. All 
samples were tested in duplicate to ensure 
reproducibility of the melt curves.  
 
Sequencing DNA and Statistical Analysis 
PCR products were sequenced in Sequencing Centre 
of Department of Molecular Biology, University of 
Veterinary Medicine and Pharmacy in Košice, Slovak 
Republic. The concentration of primer was 10 pmol/Pl. 
The template accomplished the volume of 25 Pl. The 
volume of primer was 0.5 Pl. The resulting percentage 
of nucleotide bases and amino acid of MDR1 gene 
were analyzed with the aid of BioEdit Sequence 
Alignment Editor. 
 
Statistical analysis 
The results are presented as the mean ± standard 
deviation (SD). To determine whether sample means 
are significantly different from each other at the 5 % 
significance level single factor ANOVA was used. 
 
ZĞƐƵůƚĂŶĚŝƐĐƵƐƐŝŽŶ 
The effect of docetaxel on the generation of DNA 
strand alterations derived from human adenocarcinoma 
MCF-7 cells was evaluated using the HRM. Fig. 1 
illustrates the melting curves and the derivative of 
fluorescence with respect to temperature (dF/dT) of 
DNA of control MCF-7 cells and docetaxel treated 
MCF-7 cells. For all isolates, the SYBR green 
generated highly reproducible and sensitive melt 
profiles. One peak (indicated as Tmc, Tm1, Tm250) were 
present on the melting curves offering different 
characteristics for control and docetaxel treated 
samples (Fig. 1 and Fig. 2). Biological replicates had 
identical melting patterns. For the same run, variability 
of Tm was <0.1 %, but Tm showed 2 % to 3 % 
variation between runs. Such variations can be due to 
the limited dye stability SYBR Green. 
 
Fig. 1: Representative melting curve (A) and derivative 
of fluorescence with respect to the temperature 
(dF/dT). 
 
 
Fig. 2: Representative melting curve of DNA of control 
MCF-7 cells (1), and docetaxel treated MCF-7 cells  
(2 - 1 μM, 3 - 250 μM). 
 
 
 
 
Based on 12 measurements, one melting peak was 
displayed at Tmc = 73.66 ± 2.01 °C for the control 
MCF-7, at Tm1 = 77.62 ± 1.88 °C and 
Tm250 = 82.83 ± 1.73 °C for MCF-7 at 1 μM and  
250 μM of docetaxel, respectively.  
Using MDR1 primer pairs: forward  
ƍ-CCCATCATTGCAATAGCAGG-ƍ EDFNZDUG 
ƍ-GTTCAAACTTCTGCTCCTGA-ƍ LW ZDV SRVVLEOH
to amplify fragments of genomic DNA and detect PCR 
products. In Fig. 3 and Fig. 4 there are the aligned 
nucleotide sequences of fragments of DNA of control 
MCF-7 cells (C_F, C_R) and docetaxel treated MCF-7 
cells (1_F, 1_R - 1 μM, 5_F, 5_R - 250 μM) for 
forward and backward primers, respectively.  
The sequencing results confirm different nucleotide 
sequences for both fragments of the control and 
docetaxel-treated DNA. Apparently, docetaxel 
treatment gave rise to the deletions of the bases on the 
forward end of the DNA chain. Frequency of deletions 
was increasing with the concentration of the drug. 
Except for deletions, there are transitions visible, e.g. 
RQWKHFKDLQ&B)B)RQWKHSRVLWLRQ$ĺ7RU
&B)B) RQ WKH SRVLWLRQ  7 ĺ & 2Q WKH
backward end of the DNA chain, the insertions and 
transitions of bases can be observed: transitions in the 
VDPSOH&B5B5RQSRVLWLRQV&ĺ*RULQ
&B5B5RQWKHSRVLWLRQ&ĺ$ 
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Fig. 3: The aligned nucleotide sequences of fragments of DNA of control MCF-7 cells (C_F) and docetaxel treated 
MCF-7 cells (1_F - 1 μM, 5_F - 250 μM) for forward primers. 
 
 
   
Fig. 4: The aligned nucleotide sequences of fragments of DNA of control MCF-7 cells (C_R) and docetaxel treated 
MCF-7 cells (1_R - 1 μM, 5_R - 250 μM) for backward primers. 
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Table I gives the representation of the molecular 
profile of DNA extracted from human adenocarcinoma 
MCF-7/c cells and docetaxel-treated cells - MCF-7/1  
(1 μM) and MCF-7/250 (250 μM). On the forward end, 
comparing of the relative content G+C/A+T the 
increase from 71.56 % in MCF-7/c to 76.09 % and 
78.41 % for MCF-7/1 and MCF-7/250, respectively, 
was observed. Contrary to the forward primer, the 
relative nucleotide ratio G+C/A+T for the backward 
primer decreases from 88.24 % for control set to 
82.12 % for docetaxel treated cells. As can be seen 
from Fig. 5 and Fig. 6, the alterations in amino acid 
composition coded by fragments of DNA from control 
MCF-7 cells in comparison with docetaxel treated cells 
were detected. The sequencing results did not confirm 
identical nucleotide sequences for both fragments of 
DNA. 
 
Tab. 1: The basic characteristics and nucleotide 
composition of DNA (MCF-7/c; MCF-7/1; MCF-
7/250) for the forward and the backward primer. 
 
 
 
Fig. 5: Amino acid composition of DNA (MCF-7/c; 
MCF-7/1; MCF-7/250): the forward. 
 
 
Fig. 6: Amino acid composition of DNA (MCF-7/c; 
MCF-7/1; MCF-7/250): and the backward end. 
 
ŽŶĐůƵƐŝŽŶ  
 
The melting temperature of DNA, that is defined as 
the temperature at which half of the DNA double helix 
dissociates into single strands, is related, in general, to 
the stability and the specific nucleotide sequence of the 
macromolecule. The melting curves of DNA of MCF-7 
cells in the absence and presence of docetaxel 
represented in Fig. 1 revealed a trend for increasing of 
Tm of DNA after treating the adenocarcinoma cells 
with docetaxel, suggesting that under the influence of 
the taxane DNA helix was stabilized.  
It is well-known that the efflux of the various cytotoxic 
anticancer drugs is mediated by MDR1 which affects 
the intracellular contents and intra-tumor distribution 
of compounds. Using MDR1 primer pairs, our 
sequencing results confirmed that the adenocarcinoma 
MCF-7 cells are susceptible to genomic DNA 
instability when exposed to chemotherapy treatments 
containing docetaxel. The accumulation of 
irregularities, such as insertions and deletions of the 
bases may affect critical genes involved in controlling 
both the intracellular contents and intra-tumor 
distribution of the drug and cell survival and thus guide 
the process of multiplex steps in the progression of 
breast cancer. In this context, understanding the 
problem of the transport out of the tumor cell by drug 
efflux transporters is essential when investigating 
combination therapies of drugs that are MDR1 
substrates. 
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